Jain Piyush, Lahiri Avijit
Cardiac Imaging and Research Department, Wellington Hospital, London, UK.
J Cardiometab Syndr. 2007 Summer;2(3):190-7. doi: 10.1111/j.1559-4564.2007.888105.x.
Cardiovascular disease is an escalating worldwide health problem. Effective tools to predict and prevent its development and progression are needed. Correctly diagnosing the metabolic syndrome, which identifies people at higher risk for developing diabetes mellitus and cardiovascular disease, may be valuable in guiding treatment and prevention of these major disorders. Several important definitions of the metabolic syndrome have been proposed. The authors discuss these definitions and how they vary in terms of their relationship to incident cardiovascular disease, type 2 diabetes mellitus, and surrogate markers of atherosclerosis. Establishing clarity on what is meant by the metabolic syndrome and agreement as to its underlying basis is needed to reach consensus between the many different definitions that have been proposed. This is particularly the case if it is to become a useful adjunct in clinical practice to identify those who may benefit from more intensive lifestyle interventions and more detailed short-term risk assessments.
心血管疾病是一个在全球范围内不断升级的健康问题。需要有效的工具来预测和预防其发生及发展。正确诊断代谢综合征对于指导这些主要疾病的治疗和预防可能具有重要价值,代谢综合征可识别出患糖尿病和心血管疾病风险较高的人群。已经提出了几种关于代谢综合征的重要定义。作者讨论了这些定义以及它们在与心血管疾病、2型糖尿病和动脉粥样硬化替代标志物的关系方面是如何不同的。需要明确代谢综合征的含义并就其潜在基础达成共识,以便在众多已提出的不同定义之间达成一致。如果它要成为临床实践中有用的辅助手段,用于识别那些可能从更强化的生活方式干预和更详细的短期风险评估中获益的人,情况尤其如此。